Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2013-09-20

Clinical Trial Update: Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study combining a biological therapy with temozolomide in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biological therapy
  • Temozolomide (Temozolomide)

Snippet

Sponsor: St. Luke's Medical Center | Conditions: Melanoma (Skin) | Phase 1 | Status: UNKNOWN